Fierce Pharma September 7, 2023
By Nick Paul Taylor

PhRMA has rounded up its attack ad team once again for another broadside against pharmacy benefit managers, zeroing in this time on the potential for insurers to profit from where prescriptions get filled.

In recent years, the Big Pharma trade group has responded to criticisms of drug prices by running a string of ads about the effect of PBMs. PhRMA created the blueprint for the attack ads with the spots it ran in 2019 and 2021, and it returned for another round earlier this year in the wake of Congress’ vote to pass contentious drug pricing legislation.

The latest TV spot has the same structure as the two previous ads. In the new spot, titled “Middlemen Are...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Regulations
4 top healthcare CIOs: Forbes
Trace Neuroscience Nets $101M in Series A Funding for ALS, Dementia Therapy Development
RFK Jr. vs. Vivek: Trump world's two paths for pharma regulation
Managing the Specialty Drug Cost Challenge: Is Your Pharmacy Benefits Strategy Ready for 2025?
AI in Pharma: Where, When, and How Executives are Considering it

Share This Article